Fredun Pharmaceuticals Income Statement

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Operating Revenue	6,333	4,517	3,466	2,743	2,217
Other Revenue	57.98	21.11	15.79	3.34	27.23
Revenue	6,391	4,538	3,482	2,747	2,245
Revenue Growth (YoY)	40.83%	30.35%	26.75%	22.37%	67.74%
Cost of Revenue	4,698	3,499	2,757	2,191	1,843
Gross Profit	1,693	1,039	724.71	555.79	401.99
Selling, General & Admin	329.43	513.49	344.89	278.02	252.54
Other Operating Expenses	418.28	-12.02	-1.12	-1.97	7.33
Operating Expenses	830.18	551.87	381.73	304.14	284.58
Operating Income	862.94	487.33	342.99	251.65	117.41
Interest Expense	-392.98	-204.24	-125.18	-75.62	-43.91
Interest & Investment Income	-	2.67	0.14	0.23	0.06
Currency Exchange Gain (Loss)	-	9.82	7.19	13.85	11.81
Other Non Operating Income (Expenses)	-0	-19.53	-10.62	-15.94	0.64
EBT Excluding Unusual Items	469.96	276.05	214.52	174.18	86
Gain (Loss) on Sale of Assets	-	-1.12	-	-	-
Pretax Income	469.96	274.94	214.52	175.09	86
Income Tax Expense	143.75	77.54	58.29	67.02	22.65
Net Income	326.21	197.39	156.23	108.07	63.35
Net Income to Common	326.21	197.39	156.23	108.07	63.35
Net Income Growth	65.26%	26.34%	44.57%	70.58%	214.45%
Shares Outstanding (Basic)	5	5	5	4	4
Shares Outstanding (Diluted)	5	5	5	4	4
Shares Change (YoY)	14.77%	-	3.66%	7.85%	4.06%
EPS (Basic)	66.81	42.52	33.66	24.13	15.26
EPS (Diluted)	61.23	42.52	33.66	24.13	15.26
EPS Growth	43.99%	26.34%	39.48%	58.14%	202.19%
Free Cash Flow	416.64	-351.69	-80.78	-239.03	-66.66
Free Cash Flow Per Share	78.20	-75.76	-17.40	-53.38	-16.05
Dividend Per Share	-	0.700	0.700	0.700	0.700
Gross Margin	26.49%	22.90%	20.82%	20.23%	17.91%
Operating Margin	13.50%	10.74%	9.85%	9.16%	5.23%
Profit Margin	5.10%	4.35%	4.49%	3.93%	2.82%
Free Cash Flow Margin	6.52%	-7.75%	-2.32%	-8.70%	-2.97%
EBITDA	945.41	536.47	380.41	279.3	138.74
EBITDA Margin	14.79%	11.82%	10.93%	10.17%	6.18%
D&A For EBITDA	82.47	49.14	37.42	27.65	21.33
EBIT	862.94	487.33	342.99	251.65	117.41
EBIT Margin	13.50%	10.74%	9.85%	9.16%	5.23%
Effective Tax Rate	30.59%	28.20%	27.17%	38.28%	26.33%
Revenue as Reported	6,391	4,563	3,491	2,765	2,261
Advertising Expenses	-	-	11	0.99	4.58

Source: S&P Global Market Intelligence. Standard template. Financial Sources.